(Q35843673)

10 August 2017

1 reference

title

COX-2 and its inhibition as a molecular target in the prevention and treatment of lung cancer (English)

1 reference

10 August 2017

1 reference

Zhongxing Liao

1

1 reference

10 August 2017

Luka Milas

series ordinal

2

1 reference

10 August 2017

language of work or name

1 reference

1 August 2004

1 reference

Expert Review of Anticancer Therapy

10 August 2017

published in

1 reference

10 August 2017

volume

4

1 reference

10 August 2017

issue

4

1 reference

10 August 2017

page(s)

543-560

1 reference

Cyclooxygenase mechanisms

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.4.543

COX-2 and cancer: a new approach to an old problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.4.543

Cyclooxygenase inhibitors--current status and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.4.543

G proteins: transducers of receptor-generated signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.4.543

Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.4.543

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.4.543

Xenobiotic metabolism by prostaglandin H synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.4.543

Risk of lung carcinoma among users of nonsteroidal antiinflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.4.543

COX-2 is expressed in human pulmonary, colonic, and mammary tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.4.543

Multi-faceted analyses of a highly metastatic human lung cancer cell line NCI-H460-LNM35 suggest mimicry of inflammatory cells in metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.4.543

Generation of mutagens during arachidonic acid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.4.543

Self-promotion? Intimate connections between APC and prostaglandin H synthase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.4.543

The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.4.543

Radiation protection against early and late effects of ionizing irradiation by the prostaglandin inhibitor indomethacin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.4.543

Eicosanoids and radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.4.543

Radiation response modification following molecular inhibition of epidermal growth factor receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.4.543

The importance of the eicosanoid pathway in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.4.543

Differential radioprotective effects of misoprostol in DNA repaircell proficient and-deficient or radiosensitive systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.4.543

21 January 2018

Identifiers

DOI

10.1586/14737140.4.4.543

1 reference

10 August 2017

1 reference